Trove
Sign In Sign Up

NPD

Organization
Mentions
4
Relationships
0
Events
0
Documents
2
Also known as:
The NPD Group, Inc.
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.

HOUSE_OVERSIGHT_024917.jpg

This document is an addendum to a Cowen research report dated February 25, 2019, providing mandatory regulatory disclosures and certifications. It lists Canopy Growth, GW Pharmaceuticals, Tilray, and Turning Point Brands as subject companies and details Cowen's investment banking relationships, market making activities, and compensation policies related to these entities. The document also includes a standard disclaimer regarding the informational nature of the report, limitations of liability, and contact information for the compliance department.

Research report addendum / disclosure statement
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024860.jpg

A page from a Cowen financial research report dated February 25, 2019, analyzing the U.S. Beauty industry and specifically projecting growth for CBD beauty products. It includes charts forecasting sales growth through 2020. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though the page itself contains no direct references to Jeffrey Epstein or illicit activity.

Financial research report
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search